{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:37:02Z","timestamp":1771166222026,"version":"3.50.1"},"reference-count":12,"publisher":"FapUNIFESP (SciELO)","issue":"6","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"DOI":"10.1590\/1806-3713\/e20190361","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:26:51Z","timestamp":1575923211000},"source":"Crossref","is-referenced-by-count":4,"title":["Latent tuberculosis and the use of immunomodulatory agents"],"prefix":"10.1590","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9145-0925","authenticated-orcid":false,"given":"F\u00e1bio Silva","family":"Aguiar","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio de Janeiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-6738","authenticated-orcid":false,"given":"Fernanda Carvalho de Queiroz","family":"Mello","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2019]]},"reference":[{"key":"ref1","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"ref2","series-title":"Global tuberculosis report 2019","year":"2019"},{"key":"ref3","series-title":"Manual de Recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil","year":"2019"},{"issue":"9979","key":"ref4","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar M","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"Comstock GW","year":"1974","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk mechanisms of action and clinical management","volume":"3","author":"Gardam MA","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref7","first-page":"1179","article-title":"Latent Mycobacterium tuberculosis Infection","volume":"373","author":"Getahun H","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor biology and therapeutic inhibitors","volume":"119","author":"Papadakis KA","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jlb.49.4.380","article-title":"Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates","volume":"49","author":"Denis M","year":"1991","journal-title":"J Leukoc Biol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler V","year":"1989","journal-title":"Cell"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12325-012-0037-5","article-title":"Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings","volume":"29","author":"Bonafede M","year":"2012","journal-title":"Adv Ther"},{"issue":"6","key":"ref12","article-title":"Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents a four-year experience in an endemic area","volume":"45","author":"Lopes DMA","year":"2019","journal-title":"J Bras Pneumol"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v45n6\/1806-3713-jbpneu-45-06-e20190361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T20:18:17Z","timestamp":1583180297000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132019000600103&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019]]}},"alternative-id":["S1806-37132019000600103"],"URL":"https:\/\/doi.org\/10.1590\/1806-3713\/e20190361","relation":{},"ISSN":["1806-3756","1806-3713"],"issn-type":[{"value":"1806-3756","type":"electronic"},{"value":"1806-3713","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e20190361"}}